We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
It's not surprising that companies that produce PCR products would be of interest to larger concerns given the need for better life sciences research and pharmaceutical pipelines, said market researcher Kalorama Information.